## ACGL: Arch Capital Group Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -2.7% below STRENGTH zone (4.0-10.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($88.58)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Arch Capital Group (ACGL): Revisiting Valuation After Recent 6% Share Price Rebound**
- Source: Simply Wall Street | 20251205T144140 | Somewhat-Bullish | Relevance: 100%
- Arch Capital Group (ACGL) has seen a 6% share price rebound over the past month, contrasting with a negative 6% return over the last year. Despite a cooling in annual revenue and net income growth, analysts see upside potential with a consensus price target of $108.312, suggesting the stock is currently undervalued against a fair value of $107.56. The valuation depends on contained catastrophe losses and continued premium growth in Mortgage and Reinsurance sectors.

**2. Arch Capital Group Ltd. (ACGL): A Bull Case Theory**
- Source: Finviz | 20251205T040806 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Arch Capital Group Ltd. (ACGL), highlighting its strong leadership, operational excellence, and compelling valuation despite a recent post-earnings sell-off. The company outperforms peers in key metrics and offers a robust, diversified business mix, making it an attractive long-term investment opportunity. The current market reaction is seen as disproportionate, presenting a favorable entry point for investors.

**3. Arch Capital Group Ltd. (ACGL): A Bull Case Theory**
- Source: Insider Monkey | 20251204T141500 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Arch Capital Group Ltd. (ACGL), highlighting its strong leadership, operational excellence, and diversified business mix in the insurance industry. Despite recent market overreactions to minor top-line and expense issues, ACGL is seen as undervalued with an attractive P/E ratio compared to its peers. The current pullback offers a favorable entry point for long-term investors seeking a resilient insurer with strong fundamentals.

**4. Is Arch Capital Stock Underperforming the Dow?**
- Source: Markets Financial Content | 20251204T073400 | Neutral | Relevance: 100%
- Arch Capital Group Ltd. (ACGL) has underperformed the Dow Jones Industrials Average over the past three months, six months, and 52 weeks despite its market cap of $33.6 billion. The financial services provider, headquartered in Bermuda, offers life, health, property, and mortgage insurance products. Despite recent underperformance, Wall Street analysts maintain a "Moderate Buy" rating with a potential upside of 14.9%.

**5. Roth Capital Predicts Lower Earnings for Arch Capital Group**
- Source: MarketBeat | 20251204T140804 | Somewhat-Bearish | Relevance: 100%
- Roth Capital has reduced its Q4 2025 EPS estimate for Arch Capital Group to $2.41 from $2.49, while maintaining a "Buy" rating and a $110 price target. The firm also provided earnings estimates through FY2027. Despite the reduced quarterly estimate, Arch Capital Group recently surpassed Q3 expectations with an EPS of $2.77 and strong revenue, and its stock is currently trading near $92.69 with a P/E of 8.67.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Roth Capital | $110 | $125 | -12% |
| 2025-11-17 | Morgan Stanley | $110 | $105 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Roth Capital | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 5 ($5.16M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-0.2%)
- Blackrock Inc.: 8.9% (-1.4%)
- Artisan Partners Lim: 6.5% (-0.8%)
- BAMCO Inc.: 5.2% (-4.9%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.9% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $5.2M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Forward P/E 9.9x stretched relative to 0% growth. Quality metrics strong (margin 21%). Balance sheet: strong liquidity (7513000000.0x), $2.2B free cash flow. Insider selling cluster ($5.2M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.8B |
| Beta | 0.45 |
| 52W Range | $82.45 - $97.60 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 9.9 |
| Current P/E | 9.9 |
| YoY Growth | 0.4% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 1.1% to -2.7% (-3.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.7pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 52. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.73% (CS: 30) | Weak |
| RSI_14 | 51.8 | Neutral |
| MACD Histogram | -0.12 | Bearish |
| vs SMA20 | 0.995x | Below |
| vs SMA50 | 1.017x | Above |
| vs SMA200 | 1.008x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $91.72
- **Stop Loss:** $88.58 (3.4% risk)
- **Target:** $94.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 318
- **Position Value:** $29,166.96
- **Portfolio %:** 29.17%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-10 (Est: $2.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.25 | $2.77 | +22.9% |
| 2025Q2 | $2.30 | $2.58 | +12.2% |
| 2025Q1 | $1.31 | $1.54 | +17.2% |
| 2024Q4 | $1.80 | $2.26 | +25.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*